The oral GLP-1 market has changed faster in the past six months than in the previous six years
The drugs in this class include semaglutide, liraglutide, dulaglutide, exenatide, and lixisenatide
Gorrini C, Harris IS, Mak TW
Ozempics Impact on Healthcare Providers Healthcare providers are on the front lines, tasked with balancing the therapeutic benefits of Ozempic against the potential risks highlighted by recent Ozempic lawsuits and regulatory concerns
Remove from wishlist failed
Sensitivity analysis To check the strength of the pooled effect estimate, a leave-one-out sensitivity analysis was performed by successively dropping out each study